US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist

2.749
-0.161-5.53%

Trading Aug 16 15:21 ET

117.30MMarket Cap-1454P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

2,744.51%5.18M

10,240.54%3.83M

-43.27%5.12M

2,823.53%1.99M

-64.94%2.92M

-14.95%182K

-91.42%37K

-24.73%9.03M

68K

8.32M

Operating revenue

2,744.51%5.18M

10,240.54%3.83M

-43.27%5.12M

2,823.53%1.99M

-64.94%2.92M

-14.95%182K

-91.42%37K

-24.73%9.03M

--68K

--8.32M

Cost of revenue

298.53%542K

1,573.53%1.14M

2.90%746K

338.71%272K

62.65%270K

-37.90%136K

-75.54%68K

725K

62K

166K

Gross profit

9,976.09%4.64M

8,770.97%2.69M

-47.30%4.38M

28,500.00%1.72M

-67.53%2.65M

1,020.00%46K

-120.26%-31K

-30.78%8.31M

8.15M

Operating expense

70.13%19.84M

201.60%21.29M

128.36%67.6M

258.94%22.32M

296.18%26.56M

27.93%11.66M

-6.68%7.06M

-31.01%29.6M

-26.60%6.22M

-43.02%6.71M

Selling and administrative expenses

178.29%16.52M

278.31%16.34M

171.79%47.31M

432.93%17M

410.93%20.05M

14.77%5.94M

-15.61%4.32M

-35.49%17.41M

-37.63%3.19M

-50.97%3.93M

Research and development costs

-42.03%3.32M

80.65%4.95M

66.38%20.3M

75.69%5.32M

134.17%6.51M

45.19%5.73M

12.02%2.74M

-23.42%12.2M

-9.80%3.03M

-26.12%2.78M

Operating profit

-30.91%-15.21M

-162.36%-18.6M

-196.87%-63.22M

-231.65%-20.6M

-1,751.73%-23.92M

-27.35%-11.62M

4.33%-7.09M

31.10%-21.3M

26.67%-6.21M

112.30%1.45M

Net non-operating interest income expense

-415.50%-1.98M

-444.20%-1.72M

27.95%-1.22M

-629.02%-1.51M

-1,346.27%-835K

159.85%626K

147.17%500K

59.35%-1.7M

126.73%286K

106.31%67K

Non-operating interest income

-37.22%393K

19.60%598K

475.63%2.74M

176.92%792K

455.41%822K

3,030.00%626K

2,172.73%500K

286.99%476K

959.26%286K

377.42%148K

Non-operating interest expense

--2.37M

--2.32M

82.41%3.96M

--2.31M

1,945.68%1.66M

--0

-49.43%2.17M

--0

-92.58%81K

Other net income (expense)

-5K

-11K

-70.64%-2.55M

-35,642.86%-2.5M

96.51%-50K

-1.5M

-7K

-1.43M

Special income (charges)

----

-76.55%-2.54M

---2.54M

--0

----

---1.44M

--0

---1.44M

-Less:Other special charges

----

--1.44M

--0

--1.44M

-Gain on sale of property,plant,equipment

----

---2.54M

----

--0

----

Other non- operating income (expenses)

---5K

---11K

75.86%-14K

600.00%35K

-1,100.00%-50K

----

---58K

---7K

--5K

Income before tax

-56.38%-17.19M

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

Income tax

Net income

-56.38%-17.19M

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

Net income continuous Operations

-56.38%-17.19M

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

Minority interest income

Net income attributable to the parent company

-56.38%-17.19M

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-56.38%-17.19M

-208.56%-20.33M

-173.59%-67M

-314.94%-24.61M

-29,981.93%-24.8M

-8.08%-10.99M

22.21%-6.59M

30.20%-24.49M

37.82%-5.93M

100.65%83K

Basic earnings per share

-54.17%-0.37

-193.33%-0.44

-105.56%-1.48

-285.71%-0.54

-26,326.32%-0.54

35.14%-0.24

51.61%-0.15

44.62%-0.72

60.00%-0.14

100.44%0.0021

Diluted earnings per share

-54.17%-0.37

-193.33%-0.44

-105.56%-1.48

-285.71%-0.54

-26,339.07%-0.54

35.14%-0.24

51.61%-0.15

44.62%-0.72

60.00%-0.14

100.44%0.0021

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	2,744.51%5.18M	10,240.54%3.83M	-43.27%5.12M	2,823.53%1.99M	-64.94%2.92M	-14.95%182K	-91.42%37K	-24.73%9.03M	68K	8.32M
Operating revenue	2,744.51%5.18M	10,240.54%3.83M	-43.27%5.12M	2,823.53%1.99M	-64.94%2.92M	-14.95%182K	-91.42%37K	-24.73%9.03M	--68K	--8.32M
Cost of revenue	298.53%542K	1,573.53%1.14M	2.90%746K	338.71%272K	62.65%270K	-37.90%136K	-75.54%68K	725K	62K	166K
Gross profit	9,976.09%4.64M	8,770.97%2.69M	-47.30%4.38M	28,500.00%1.72M	-67.53%2.65M	1,020.00%46K	-120.26%-31K	-30.78%8.31M	6K	8.15M
Operating expense	70.13%19.84M	201.60%21.29M	128.36%67.6M	258.94%22.32M	296.18%26.56M	27.93%11.66M	-6.68%7.06M	-31.01%29.6M	-26.60%6.22M	-43.02%6.71M
Selling and administrative expenses	178.29%16.52M	278.31%16.34M	171.79%47.31M	432.93%17M	410.93%20.05M	14.77%5.94M	-15.61%4.32M	-35.49%17.41M	-37.63%3.19M	-50.97%3.93M
Research and development costs	-42.03%3.32M	80.65%4.95M	66.38%20.3M	75.69%5.32M	134.17%6.51M	45.19%5.73M	12.02%2.74M	-23.42%12.2M	-9.80%3.03M	-26.12%2.78M
Operating profit	-30.91%-15.21M	-162.36%-18.6M	-196.87%-63.22M	-231.65%-20.6M	-1,751.73%-23.92M	-27.35%-11.62M	4.33%-7.09M	31.10%-21.3M	26.67%-6.21M	112.30%1.45M
Net non-operating interest income expense	-415.50%-1.98M	-444.20%-1.72M	27.95%-1.22M	-629.02%-1.51M	-1,346.27%-835K	159.85%626K	147.17%500K	59.35%-1.7M	126.73%286K	106.31%67K
Non-operating interest income	-37.22%393K	19.60%598K	475.63%2.74M	176.92%792K	455.41%822K	3,030.00%626K	2,172.73%500K	286.99%476K	959.26%286K	377.42%148K
Non-operating interest expense	--2.37M	--2.32M	82.41%3.96M	--2.31M	1,945.68%1.66M	--0	--0	-49.43%2.17M	--0	-92.58%81K
Other net income (expense)	-5K	-11K	-70.64%-2.55M	-35,642.86%-2.5M	96.51%-50K			-1.5M	-7K	-1.43M
Special income (charges)	----	----	-76.55%-2.54M	---2.54M	--0	----	----	---1.44M	--0	---1.44M
-Less:Other special charges	----	----	----	----	----	----	----	--1.44M	--0	--1.44M
-Gain on sale of property,plant,equipment	----	----	---2.54M	----	----	----	----	--0	----	----
Other non- operating income (expenses)	---5K	---11K	75.86%-14K	600.00%35K	-1,100.00%-50K	----	----	---58K	---7K	--5K
Income before tax	-56.38%-17.19M	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K
Income tax
Net income	-56.38%-17.19M	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K
Net income continuous Operations	-56.38%-17.19M	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K
Minority interest income
Net income attributable to the parent company	-56.38%-17.19M	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-56.38%-17.19M	-208.56%-20.33M	-173.59%-67M	-314.94%-24.61M	-29,981.93%-24.8M	-8.08%-10.99M	22.21%-6.59M	30.20%-24.49M	37.82%-5.93M	100.65%83K
Basic earnings per share	-54.17%-0.37	-193.33%-0.44	-105.56%-1.48	-285.71%-0.54	-26,326.32%-0.54	35.14%-0.24	51.61%-0.15	44.62%-0.72	60.00%-0.14	100.44%0.0021
Diluted earnings per share	-54.17%-0.37	-193.33%-0.44	-105.56%-1.48	-285.71%-0.54	-26,339.07%-0.54	35.14%-0.24	51.61%-0.15	44.62%-0.72	60.00%-0.14	100.44%0.0021
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall